Suppr超能文献

左心室辅助装置植入术后接受心脏康复治疗患者的结局

Outcomes of Patients Referred for Cardiac Rehabilitation After Left Ventricular Assist Device Implantation.

作者信息

Shaaban Adnan, Schultz Jessica, Leonard John, Martin Cindy M, Kamdar Forum, Alexy Tamas, Thenappan Thenappan, Pritzker Marc, Shaffer Andrew, John Ranjit, Cogswell Rebecca

机构信息

From the Division of Internal Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.

Division of Cardiology, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.

出版信息

ASAIO J. 2023 Mar 1;69(3):304-308. doi: 10.1097/MAT.0000000000001799. Epub 2022 Aug 2.

Abstract

A single-center continuous-flow left ventricular assist device (LVAD) cohort (n = 503) was reviewed for patients with information on cardiac rehabilitation (CR) participation (n = 273) over a 13-year period. The analysis was then limited LVAD recipients who fit into three main CR categories: those who graduated CR (n = 138), those who were able to but declined participation (n = 61), and those who were too sick to complete or start CR (n = 28). To assess the association between CR categories and mortality and hospitalizations on LVAD support, multivariate cox regression and negative binomial regression analyses were performed, respectively. Among those who started CR and had the opportunity to finish (enough follow-up time, insurance coverage), 79% graduated. Those who graduated CR had a 96% survival at 1 year (95% confidence interval [CI], 91-98). Compared with the graduated group, those in the too sick group had an increased hazards rate of mortality (hazard ratio, 2.85; 95% CI, 1.49-5.44; p < 0.01) and an increase in the incidence rate of hospitalizations (incidence rate ratio, 1.74; 95% CI, 1.14-2.66, p = 0.01). This study is the largest to date to report outcomes of LVAD recipients referred for CR. The lower readmission rates and high survival in the group that graduated CR provides further evidence for the safety of CR in LVAD recipients.

摘要

回顾了一个单中心连续流左心室辅助装置(LVAD)队列(n = 503)中在13年期间有心脏康复(CR)参与信息的患者(n = 273)。然后将分析局限于符合三个主要CR类别的LVAD接受者:完成CR的患者(n = 138)、有能力但拒绝参与的患者(n = 61)以及病情过重无法完成或开始CR的患者(n = 28)。为了评估CR类别与LVAD支持下的死亡率和住院率之间的关联,分别进行了多变量考克斯回归分析和负二项回归分析。在开始CR并有机会完成(有足够随访时间、保险覆盖)的患者中,79%完成了CR。完成CR的患者1年生存率为96%(95%置信区间[CI],91 - 98)。与完成组相比,病情过重组的死亡风险率增加(风险比,2.85;95% CI,1.49 - 5.44;p < 0.01),住院发生率增加(发生率比,1.74;95% CI,1.14 - 2.66,p = 0.01)。本研究是迄今为止报告转介接受CR的LVAD接受者结局的最大规模研究。完成CR组较低的再入院率和高生存率为CR在LVAD接受者中的安全性提供了进一步证据。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验